Our extensive product range meets stringent quality standards, ensuring safety and efficacy
Med Gas Res 7(3):212219
In the landmark REWIND cardiovascular outcomes trial the longest GLP-1 outcomes trial ever conducted at a median 5.4 years Trulicity reduced the risk of major cardiovascular events (heart attack, stroke, or cardiovascular death) by 12% across a broad population that included primarily patients without established cardiovascular disease
Olympia Pharmaceuticals co-founders discuss how theyre pivoting in light of FDAs decision
Clinical research shows that Wegovy can deliver significant weight loss results, often comparable to those seen with Mounjaro, making it one of the most effective options currently available
PlexusDx recognizes that individual responses to tirzepatide vary, which is why personalization through baseline health assessment and, optionally, the Precision Peptide Genetic Test helps identify how your genetics influence medication response and potential side effects